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VITROCELLOver the past three decades, the genotoxic effects of cigarette smoke have generally been evaluated in
non-human cell models after exposure to particulate phase, gas phase, or cigarette smoke condensate,
rather than the whole smoke aerosol itself. In vitro setups using human cell lines and whole smoke expo-
sure to mimic actual aerosol exposure should more accurately reﬂect human cigarette smoke exposure.
We investigated the VITROCELL 24 air–liquid interface exposure system in combination with the comet
assay to assess DNA damage in two different human lung epithelial cell lines exposed to whole smoke.
Results showed a repeatable and reproducible dose–response relationship between DNA damage and
increased whole smoke dose in both cell lines. Thus, the combination of the comet assay with the VITRO-
CELL 24 represents a valuable new in vitro test system to screen and assess DNA damage in human lung
cells exposed to whole smoke.
 2013 The Authors. Published by Elsevier Ltd. Open access under CC BY-NC-SA license. 1. Introduction WS aerosol (Fukano et al., 2006; Scian et al., 2009). In addition, theTobacco smoke contains more than 5000 chemical constituents
(Rodgman and Perfetti, 2009), some of which are genotoxic and can
cause chemical modiﬁcations to DNA which may lead to genetic
mutations that predispose individuals to smoking-related cancers
(Hecht, 1999, 2008). The comet assay is able to detect a wide range
of DNA damage and can therefore be used to determine potentially
important mechanistic steps in DNA damage formation and repair
(Faux et al., 2009; Burlakova et al., 2010; Deng et al., 2009;
Gackowski et al., 2003; Gao et al., 2003; Paz-Elizur et al., 2003;
Taioli, 2008; Moktar et al., 2009).
A recent publication reported that the majority of in vitro assays
used to assess the genotoxic potential of cigarette smoke do not
use whole smoke (WS) (Johnson et al., 2009) or even aerosol expo-
sure. Instead, the particulate phase and the gas phase of WS are
collected and tested separately or cigarette smoke condensate is
used, which does not take into account the dynamic nature of freshparticulate phase alone and the gas phase alone may not contain
all of the constituents that contribute to the toxic effects of ciga-
rette smoke (Johnson et al., 2009; Borgerding and Klus, 2005), as
some compounds may be formed by chemical reactions between
individual smoke components (Liu et al., 2010; Rickert et al.,
2007). This limits the interpretation of previous genotoxicity eval-
uations of smoke and does not necessarily reﬂect the true geno-
toxic potential of WS.
Most of the assays evaluated by Johnson et al. (2009) utilize ro-
dent cells from non-respiratory tract organs submerged in medium
prior to smoke exposure (Carnevali et al., 2003; Muller and Gebel,
1998). This does not reﬂect the direct exposure of respiratory tract
cells to smoke as in the in vivo situation and may add further com-
plexity and uncertainty when extrapolating to the human situa-
tion. A recent model, the air–liquid interface (ALI) culture,
enables the evaluation of toxicity in a setting that better represents
the human smoking situation (Aufderheide et al., 2002; Fukano
et al., 2004, 2006; Komori et al., 2008; Okuwa et al., 2010; Wolz
et al., 2002). In this model, cells come into direct contact with
the smoke aerosol on their apical surface and with a liquid medium
on their basal surface, thus mimicking the exposure mode of hu-
man respiratory tract cells to tobacco smoke (Komori et al., 2008).
In the present study, the VITROCELL 24 air–liquid exposure
system (VITROCELL Systems GmbH, Waldkirch, Germany) was
investigated in combination with the comet assay to assess DNA
damage in 2 human lung cell lines, human lung adenocarcinoma
1988 S. Weber et al. / Toxicology in Vitro 27 (2013) 1987–1991cells (A549) and human bronchial epithelial cells (BEAS-2B), after
exposure to WS. While similar WS exposure systems have been
successfully used with human bronchial epithelial cell lines
(Fukano et al., 2006; Massey et al., 1998; Wolz et al., 2002) the
VITROCELL 24 has the added advantage of enabling exposure to
multiple doses of WS within the same plate in a single run because
it uses 24-well plates. Results showed a repeatable and reproduc-
ible dose–response relationship between DNA damage and
increased WS dose in both cell lines, demonstrating that the
combination of the comet assay with the VITROCELL 24 is a valu-
able new in vitro test system to screen and assess DNA damage in
human lung cells exposed to cigarette smoke.
2. Materials and methods
2.1. Study design
Human lung cell lines A549 and BEAS-2B were exposed to di-
luted WS from the Reference Cigarette 3R4F in the VITROCELL
24 and DNA damage was evaluated using the comet assay. Five
independent biological assay replicates were performed per cell
line: 3 assays on the same day and 2 assays on 2 different days.
The cells from 4 wells per dilution, per plate, were run in triplicate
(cells split on 3 slides) for each independent assay and both intra-
day and inter-day variability were assessed. An overview of the
study design is presented in Fig. 1.
2.2. Cells
A549. cells and BEAS-2B cells (American Type Culture Collec-
tion, Manassas, VA, USA; number CCL-185™ and CRL-9609™,
respectively) were cultured in Dulbecco’s modiﬁed Eagle medium
containing 10% fetal bovine serum at 37 C in a humidiﬁed incuba-
tor with 5% CO2 in air and 85% relative humidity. Cultures wereFig. 1. Overall study design. (A) Cells within the 24-well plate were exposed to WS
at increasing concentrations of WS or SA, and (B) a 4-well incubator control was
maintained for each assay. (C) A pooled sample from 4-wells per concentration of
the exposed plate and (D) internal controls were prepared for each comet assay
electrophoresis run. At least 3 slides per culture, with 50 nuclei per slide, were
prepared for analysis (E). C1–C6, concentration 1–6; DMSO, dimethyl sulfoxide; IC,
incubator control; MMS, methyl methanesulfonate; SA, synthetic air; WS, whole
smoke. Note: DMSO and MMS were treatments for the internal standards.screened for the presence of mycoplasma contamination using
the Myco Alert Mycoplasma Detection Kit (Lonza, Rockland, ME,
USA).2.3. Smoke generation and application
Cigarettes (University of Kentucky Reference Cigarette 3R4F;
total particulate matter yield approximately 10 mg/cig) were
smoked on the VC 10 smoking robot (Fig. 2A) in conformity withFig. 2. The VITROCELL 24 exposure system. (A) The software-controlled smoking
robot (VC 10), where the cigarette smoke is generated; (B) the dilution chamber,
where the smoke is mixed dynamically with deﬁned volumes of humidiﬁed
synthetic air injected at oppositely arranged sites, thereby creating deﬁned smoke
dilutions; and (C) the exposure chamber in which 6 channels comprising 4 cell-
covered membranes each are placed at one time and treated directly with the
diluted smoke from the dilution chamber at the air/liquid interface.
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regimen (ISO, 2000).
Two subsequent runs of 5 cigarettes were performed for each
exposure, the smoking run was stopped after 7 puffs, and the over-
all exposure time was 14 min. Fresh WS (5 puffs per min-
ute  35 ml = 175 ml/min) from 5 cigarettes was passed puff-
wise through the dilution system (Fig. 2B) and diluted with at least
5 different velocities of humidiﬁed synthetic air (SA; 85% nitrogen
and 15% oxygen; Praxair, Düsseldorf, Germany). Dilution velocities
ranged from 4 l/min to 0.2 l/min (from low to high smoke concen-
trations; Table 1).
The aerosol was passed from one row to the next of the 24-
well chamber while the dilution was increased stepwise (shown
in Figs. 2B and 2C). At each well, permanent suction was applied
so that 2 ml/min of freshly diluted WS was administered
(Fig. 2C).
For each smoke dilution, at least 3 cultures were prepared. Dilu-
tions and number of cigarettes per dilution are shown in Table 1.
Theoretical percentages of cigarettes were calculated according
to the formula:Theoretical % of cigarette ¼
No: of Cig: Smoke administered per wellðml=minÞ  Exposure timeðminÞ
Cig: count Puff volumeðmlÞ  Puff per cig:þ Dilution velocityðml=minÞ  exposure timeðminÞ  1002.4. Cell viability
Following WS exposure, the microwell inlays were trypsinized
and cells were immediately stored on ice, pooled, and prepared
for viability assessments. Determination of viable cells in each cell
culture sample was performed using an automated cell counter
(CASY TTC Module; Roche Innovatis AG, Mannheim, Germany).
Results of the SA group were set at 100% compared to WS-treated
samples.Table 1
Theoretical applied number and percentage of cigarettes (5 puffs per min-
ute  35 ml = 175 ml/min).
Cigarettes
smoked
Dilution air velocity
(l/min)
Number of cigarettes
per insert
Theoretical%
of cig.
10 4.0 0.0048 0.48
10 3.0 0.0063 0.63
10 2.5 0.0075 0.53
10 2.0 0.0092 0.92
10 1.5 0.0119 1.19
10 1.0 0.0170 1.70
10 0.5 0.0296 2.96
10 0.2 0.0533 5.332.5. Comet assay
Slides were degreased for 1 h with 1/2 (v/v) diethyl ether +
ethanol (70%), then for 30 min with ethanol (70%), and allowed
to air-dry. Each slide was covered with 1.5% (w/v) normal melting
point agarose dissolved in distilled water and then kept at room
temperature to allow the agarose to solidify.
Cells were suspended in 300 ll of 1% low melting point agarose
at 37 C. Up to 100 ll of the cell suspension (approximately
10,000–30,000 cells per slide) was pipetted onto agarose-coated
slides, coverslipped, and placed on ice for approximately 10 min
until the agarose solidiﬁed. Coverslips were removed and the slides
were immersed overnight at 4 C in freshly prepared, cold lysing
solution (2.5 mol/l NaCl, 100 mmol/l Na2EDTA, 10 mmol/l Tris;
pH 10, with 1% v/v Triton X-100 added just before use).
Slides were rinsed in distilled water and washed in phosphate-
buffered saline for 5 min, then arranged side by side in a horizontal
gel electrophoresis tank and allowed to equilibrate in the electro-
phoresis buffer (1 mmol/l Na2EDTA and 300 mmol/l NaOH,
pH > 13) at 4 C for 30 min. Electrophoresis was then conducted
at 4 C for 30 min at constant voltage (25 V). All slides from the 6
cultures of the VITROCELL 24, the internal standards, and the
incubator control were processed in one electrophoresis run.Slides were washed in phosphate-buffered saline (pH 7.5 [3
times/5 min]) and dehydrated in a series of ethanol baths
(Pérez-Llanoa et al., 2010), stained with 30 ll of 10 lg/ml ethidium
bromide in distilled water, and examined using a ﬂuorescence
microscope equipped with a 100-W mercury lamp with an excita-
tion ﬁlter of 515–560 nm and a barrier ﬁlter of 590 nm. Photomi-
crographs of single cells were taken at 400 magniﬁcation using
the high-resolution camera model Stingray F046B IRF (Allied
Vision Technologies GmbH, Stadtroda, Germany).
Images of stained slides were analyzed with the Comet Assay
Version IV Image Analysis System (Perceptive Instruments, Steeple
Bumpstead, UK). DNA migration values were expressed as tail
intensity values (percentage of whole comet intensity) according
to the formula: Sum of all intensity values less the intensity values
from the mirrored head region. Migration values were determined
in a minimum of 50 randomly selected cells per slide.
2.6. Statistical analysis
Tail intensity values of each WS-exposed group were compared
to the SA group using one-way analysis of variance (ANOVA) fol-
lowed by Dunnett’s multiple comparison test. The mean of 3 slidesfrom each group was compared to the SA control for each cell line
and each assay. A value of P < 0.05 was considered to be statisti-
cally signiﬁcant for comparison between data sets.
3. Results
3.1. Effect of WS exposure on viability
In both cell lines, the majority of the cultures exposed to WS
showed viability above 75% (Figs. 3 and 4), mainly for the highest
dose groups. At the highest WS concentration (0.2 l/min dilution
velocity), viability ranged from 40% to 70% for A549 cells and from
55.7% to 90% for BEAS-2B cells, with 5 out of 5 assay replicates be-
low 75% viability for the A549 cell line and 4 out of 5 for the BEAS-
2B cell line. At lower smoke concentrations, viability for the A549
cell line was below 75% for 1 out of 5 assay replicates at 1.5 l/min
dilution velocity and 2 out of 5 at 1.0 l/min and 0.5 l/min dilution
velocity, with viability values ranging from 48% to 74% for the
A549 cell line and 1 out of 5 assays at 4.0 l/min and 3 out of 5 as-
says at 1.5 l/min dilution velocity, with viability values ranging
from 47.5% to 73%.
Fig. 3. DNA damage and viability in A549 cells after WS exposure. Signiﬁcant dose-dependent increases in DNA damage compared to control were observed for intra-day (A)
and inter-day assays (B). Exp, experiment; SA, synthetic air; =, no signiﬁcant difference; signiﬁcantly different from SA: P < 0.05 to P < 0.01; signiﬁcantly different from SA:
P < 0.01 to P < 0.001; signiﬁcantly different from SA: P < 0.001.
Fig. 4. DNA damage and viability in BEAS-2B cells after WS exposure. Signiﬁcant increases in DNA damage were observed for both intra-day (A) and inter-day (B) samples,
with the exception of the highest dilution of assays assessed for the inter-day experiment (A), which was not different from control. Exp, experiment; SA, synthetic air; =, no
signiﬁcant difference; signiﬁcantly different from SA: P < 0.05 to P < 0.01; signiﬁcantly different from SA: P < 0.01 to P < 0.001; signiﬁcantly different from SA: P < 0.001.
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For all experiments and both cell lines, a clear dose-dependent
increase in DNA damage was seen, demonstrating the genotoxic
potential of WS. In A549 cells, the comparison between the control
and all WS dilutions showed statistically signiﬁcant differences
with regard to DNA damage, expressed as tail intensity
(P < 0.001). The increases in response to WS over the control varied
from 5.2-fold to 17.3-fold, indicating a clear dose–response for all
assays (Fig. 3. For the BEAS-2B cell line, the increase of DNA dam-
age in treated cells was also statistically signiﬁcant when com-
pared to control (P < 0.001). The manifold increases in damage in
response to WS over the SA control were up to 3.9-fold, demon-
strating a clear genotoxic effect. Exceptions were found for 2 of 3
experiments (same-day assay) of the highest dilution (4 l/min),
where no statistically signiﬁcant difference was seen (Fig. 4A).3.3. Variability of the assay
Repeatability and reproducibility were evaluated by determin-
ing the relative standard deviation (RSD) between each assay per-
formance for each cell line. For the A549 cell line, RSD valuesranged from 4.61% to 37.44% for repeatability and from 5.90% to
39.78% for reproducibility (Table 2). For the BEAS-2B cell line,
RSD values ranged from 6.36% to 16.83% for repeatability and from
9.73% to 22.66% for reproducibility (Table 3).4. Discussion
The DNA damage observed following WS applications occurred,
in most cases, with cell viability above 75%, which supports the be-
lief that the high tail intensities observed in this study are linked to
genotoxic events rather than to cytotoxic events. Effectively, viabil-
ity of less than 75% signals a potential cytotoxic effect of the treat-
ment, which may lead to related nonspeciﬁc DNA damage, which is
why this value has been recommended as the cut-off point for
which genotoxic evaluations can be determined with the exclusion
of DNA damage due to cytotoxic events (Henderson et al., 1998).
DNA damage quantiﬁcation was repeatable and reproducible.
Assay variability was assessed using the RSD. An RSD value below
25% is generally regarded as acceptable as an average precision
standard for a cell-based assay (http://www.sitcancer.org/meet-
ings/am04/workshop_presentations/disis.pdf). The high variability
seen for three of the twelve A549 samples is most likely not due to
Table 2
Genotoxicity in A549 cells, variability values.
A549 Synthetic
air
Dilution of whole smoke (l/min)
2 1.5 1 0.5 0.2
Mean 7.14 42.08 54.77 68.32 79.59 80.92
Repeatability variance 7.14 77.04 16.82 51.03 22.02 13.90
Between-day variance 0.92 49.211 2.78 0 0 20.20
Reproducibility variance 8.06 126.25 19.60 51.03 22.02 34.10
Repeatability RSD (%) 37.44 20.86 7.49 10.46 5.90 4.61
Between-day RSD (%) 13.44 16.67 3.05 0 0 5.55
Reproducibility RSD (%) 39.78 26.70 8.08 10.46 5.90 7.22
RSD = relative standard deviation.
Table 3
Genotoxicity in BEAS-2B cells, variability values.
BEAS-2B Synthetic
air
Dilution of whole smoke (l/min)
3 2 1.5 1
Mean 25.85 51.94 69.65 72.83 80.22
Repeatability variance 18.92 37.25 55.37 43.32 26.01
Between-day variance 15.40 68.89 50.47 88.197 34.86
Reproducibility variance 34.33 106.14 105.84 131.52 60.87
Repeatability RSD (%) 16.83 11.75 10.68 9.04 6.36
Between-day RSD (%) 15.18 15.98 10.20 12.90 7.36
Reproducibility RSD (%) 22.66 19.83 14.77 15.75 9.73
RSD = relative standard deviation.
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BEAS-2B data showed acceptable variability data. Whether the
A549 variability is due to speciﬁc cell characteristics needs to be
further investigated to qualify this cell line as suitable for this as-
say combination.
In conclusion, the VITROCELL 24 exposure system in combina-
tion with the comet assay is a valid, reliable, and promising exper-
imental model for evaluating in vitro DNA damage following
cigarette whole smoke exposure in human lung epithelial cells.
Its ﬂexibility and the ability to process 24 samples per plate in a
repeatable and reproducible manner make it a powerful tool for
screening and assessing the genotoxic potential of a wide range
of tobacco aerosols in different cell lines.
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